Top Markets
#1 Purr Purr +55.52%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +49.56%
#4 Non-Playable Coin Non-Playable Coin +29.16%
#5 StonkBroker StonkBroker +28.75%
#6 ApeX ApeX +27.06%
#7 Kinetiq Kinetiq +24.33%
#8 Pudgy Penguins Pudgy Penguins +21.56%
#9 Wrapped STX (Velar) Wrapped STX (Velar) +21.07%
#10 OriginTrail OriginTrail +20.87%
Coin of the day
Purr Purr
Settings
Language
ENGLISH
Currency
USD
Theme
Onconic Therapeutics Onconic Therapeutics

Onconic Therapeutics

476060
Rank in Stocks #21275
Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise,... Onconic Therapeutics, Inc. operates as a biopharmaceutical enterprise, primarily dedicated to the discovery and advancement of novel therapeutic solutions. Its research and development initiatives principally focus on creating new medications for acid-related ailments and various oncological conditions. This company was established on May 7, 2020, and maintains its principal office in Seoul, South Korea.
Share Price
$10.04
Last synced: 2026-08-21
Market Cap
$111.12M
Change (1 day)
-1.43%
Change (1 year)
-40.73%
Country
KR
Trade Onconic Therapeutics (476060)

Category

Healthcare
Earnings for Onconic Therapeutics (476060)
Earnings in 2026 TTM: 0
According to Onconic Therapeutics latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Onconic Therapeutics from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH